This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit ManagedCareCGM.com

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

CanadaCGM.com Expert Interview with
Michael C. Riddell, PhD

Suzanne Lepage, a private health plan strategist with over 20 years in the
group insurance industry, is joined by Michael C. Riddell, PhD, Professor,
School of Kinesiology and Health Science, Faculty of Health, York University
diabetes registry recently published in Diabetic Medicine.

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated
type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose
Monitoring (rtCGM) provides a cost-effective disease management option relative to
SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM
to be transformative for many people living with diabetes.

Featured Article

CGM use Lowers Hospitalizations, may Reduce Mortality in Type 1 and Type 2 Diabetes

New Video Resource

Diabetes Canada Clinical Practice Guidelines:
Recommendations for
Continuous Glucose Monitoring (CGM)

Click Here to Watch Now

Featured Conference Update

Latest Research in Diabetes Technology:
Highlights from ATTD 2022

Featured Update

2021 Update from the Diabetes Canada Clinical Practice Guidelines
Expert Working Group on Blood Glucose Monitoring
in Adults and Children with Diabetes

Featured Publication

Comparing real-time and intermittently scanned continuous glucose monitoring in adults
with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized
controlled trial [Summary]

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycemia – Diabetic Medicine – 2018

Read More

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study – Journal of Clinical Endocrinology & Metabolism – 2018

Read More

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program – Diabetes Technology & Therapeutics – 2018

Read More

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring – Diabetes Care – 2018

Read More

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial – JAMA – 2017

Read More

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial – JAMA – 2017

Read More